Free Trial
→ Trump’s treachery (From Porter & Company) (Ad) Buy CTOR Stock  Free CTOR Stock Alerts

Citius Oncology (CTOR) SEC Filings & 10K Form

Citius Oncology logo
$0.88 -0.01 (-1.63%)
Closing price 05/21/2025 04:00 PM Eastern
Extended Trading
$0.87 -0.01 (-0.86%)
As of 05/21/2025 06:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Citius Oncology SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
3:45 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:30 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/06/2025
8:22 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
3:30 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-K/A
01/07/2025
8:10 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
7:30 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:10 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/27/2024
4:00 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
12/16/2024
4:05 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mayersohn Joel David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:05 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:06 PM		Bartushak Jaime (Reporting)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:06 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
MCGRATH DENNIS M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:07 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Dutia Suren G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:07 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:08 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Smith Robert Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:09 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
3:09 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Holuka Eugene Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:08 PM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Hudson Bay Capital Management LP (Filed by)
Form SC 13G/A
09/13/2024
7:30 AM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:15 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
8:23 AM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
WOLVERINE ASSET MANAGEMENT LLC (Filed by)
Form SC 13G/A
08/30/2024
3:05 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4/A
08/16/2024
4:25 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
3:34 PM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Citius Pharmaceuticals, Inc. (Filed by)
Form SC 13D
08/15/2024
11:53 AM		10XYZ Holdings LP (Filed by)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Form SC 13D/A
08/14/2024
5:19 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Webb Carol (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:19 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Citius Pharmaceuticals, Inc. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:20 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
MCGRATH DENNIS M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:20 PM		Bartushak Jaime (Reporting)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:21 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mazur Leonard L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:22 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Czuczman Myron (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:23 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:23 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Smith Robert Joseph (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:24 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Dutia Suren G (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2024
5:24 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Webb Carol (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:25 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Citius Pharmaceuticals, Inc. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:26 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
MCGRATH DENNIS M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:26 PM		Bartushak Jaime (Reporting)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:27 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Mazur Leonard L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:28 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Czuczman Myron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
5:28 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
HOLUBIAK MYRON Z (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump’s treachery (Ad)

Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.

Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma
08/14/2024
5:29 PM		CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
CITIUS ONCOLOGY, INC. (Issuer)
Citius Oncology (Issuer)
Dutia Suren G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:33 PM		CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
CITIUS ONCOLOGY, INC. (Subject)
Citius Oncology (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
08/09/2024
3:22 PM		CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
CITIUS ONCOLOGY, INC. (Filer)
Citius Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2024
7:45 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
2:39 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2024
2:40 PM		TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
Citius Oncology (Subject)
Form 425
07/14/2024
11:15 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form EFFECT
07/12/2024
4:20 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 424B3
07/11/2024
2:50 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form S-4/A
07/11/2024
5:16 AM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form S-4/A
06/18/2024
12:35 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
12:36 PM		TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
Citius Oncology (Subject)
Form 425
06/17/2024
4:30 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form S-4/A
06/06/2024
4:28 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
4:29 PM		TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
TenX Keane Acquisition (Subject)
Citius Oncology (Subject)
Form 425
05/21/2024
2:07 PM		TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
TenX Keane Acquisition (Filer)
Citius Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CTOR) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners
July 2025 Rule Change to Impact Retirement Investors
There's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...
Premier Gold Co | Sponsored
A new financial chapter
Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...
Porter & Company | Sponsored
The Secret Map of America, Declassified…
Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...
Banyan Hill Publishing | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
Elon’s backup plan for AI
Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...
True Market Insiders | Sponsored
Exclusive Offer: Target 100% Returns Now
Brace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...
ProsperityPub | Sponsored
Prepare now for May 31 event
Prepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...
Stansberry Research | Sponsored